Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MDGL
#804
Madrigal Pharmaceuticals, Inc. Common Stock
517.680
0
USD
-1.39%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-1.39%
Mudança mensal
+15.85%
Mudança em 6 meses
+22.21%
Mudança anual
+22.21%
Fechamento anterior
524.990
0
Abrir
518.170
0
Bid
Ask
Mínimo
516.840
0
High
519.230
0
Volume
230
Mercados
Ações
Cuidados de saúde
MDGL
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
22.08 M
22.2 M
22.29 M
22.71 M
22.94 M
—
Valuation ratios
Enterprise value
6.83 B
7.29 B
6.68 B
10.46 B
13.5 B
37.93 B
Price to earnings ratio
-14.09
-18.57
-23.94
-35.83
-45.32
-123.66
Price to sales ratio
36.44
22.67
12.87
13.72
13.63
62.89
Price to cash flow ratio
-14.41
-18.08
-21.41
-61.13
-68.92
-169.55
Price to book ratio
8.7
2.31
2.25
3.62
21.68
29.85
Enterprise value to EBITDA ratio
-13.75
-17.16
-21.59
-34.08
-45.24
-118.07
Profitability ratios
Return on assets %
-0.06
-0.07
-0.04
-0.08
-0.05
-0.25
Return on equity %
-0.08
-0.1
-0.06
-0.18
-0.1
-0.44
Return on invested capital %
-1 640.46
—
—
—
-974.02
—
Gross margin %
100
96.71
100
100
100
396.71
Operating margin %
-64.84
-57.79
-22.18
-39.68
-18.56
-138.21
EBITDA margin %
-61.16
-60.8
-22
-39.55
-18.44
-140.8
Net margin %
-57.51
-53.36
-19.87
-39.75
-18.24
-131.22
Liquidity ratios
Quick ratio
5.9
5.58
4.78
3.26
3.77
17.4
Current ratio
6.1
5.91
5.11
3.44
4.01
18.47
Inventory turnover
—
0.1
—
—
—
—
Asset turnover
0.1
0.13
0.21
0.24
0.24
0.83
Solvency ratios
Debt to assets ratio
0.11
0.12
0.12
0.25
0.27
0.75
Debt to equity ratio
0.16
0.17
0.17
0.54
0.56
1.44
Long term debt to total assets ratio
0.11
0.12
0.12
0.25
0.27
0.75
Long term debt to total equity ratio
0.16
0.17
0.17
0.54
0.56
1.44
Per share metrics
Operating cash flow per share
-4.91
-4.02
-2.12
3.55
-5.95
-8.54
EBIT per share
-2.99
-3.79
-2.13
-5.07
-2.66
-13.65
EBITDA per share
-2.97
-3.78
-2.11
-5.05
-2.64
-13.58
Total debt per share
5.53
5.34
5.33
15.11
15.15
40.93
Cash per share
43.78
38.39
36.12
49.58
43.84
167.93
Net current asset value per share
48.56
44.72
45.18
59.9
55.53
205.33
Tangible book value per share
35.24
31.96
31.14
27.5
26.54
117.13
Working capital per share
40.6
37.15
36.33
42.49
41.7
157.67
Book value per share
35.46
32.17
31.34
27.83
26.86
118.21
Notícias
Wolfe Research reitera classificação Peerperform para ações da Madrigal
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?
Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?
ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms
ALT Pemvidutide Explained: What Makes It Different in MASH
Tracking John Paulson’s Paulson & Company Portfolio – Q4 2025 Update
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
Vice-presidente executiva da Madrigal Pharmaceuticals vende US$ 854 mil em ações
Madrigal Pharmaceuticals EVP Dier sells $854k in stock
CEO da Madrigal Pharmaceuticals vende US$ 718 mil em ações
Madrigal Pharmaceuticals CEO Sibold sells $718k in shares